申请人:The Boots Company PLC
公开号:US04710506A1
公开(公告)日:1987-12-01
Novel thienopyridones with antihypertensive activity have the formula I, ##STR1## wherein the ring A represents an optionally substituted thiophene ring; m is 0 or 1; n is 0, 1 or 2; R is lower alkyl and R.sub.1 is lower alkyl. The fused thieno-ring may carry one or two substituents. Formula I encompasses thieno[3,2-b]pyridones, thieno[3,4-b]pyridones and thieno[2,3-b]pyridones. Processes for preparing the novel thienopyridones and pharmaceutical compositions containing them are described. Pharmaceutically acceptable acid addition salts of the compounds of formula I are also described. The thienopyridones of formula I are antihypertensive agents and are also indicated for use in treating heart failure and ischaemic heart disease.
新型具有降压活性的噻吩吡啶酮具有以下式I,其中环A代表可选择地取代的噻吩环;m为0或1;n为0、1或2;R为低碳基,R.sub.1为低碳基。融合的噻吩环可以携带一个或两个取代基。式I包括噻吩[3,2-b]吡啶酮,噻吩[3,4-b]吡啶酮和噻吩[2,3-b]吡啶酮。描述了制备新型噻吩吡啶酮和含有它们的药物组合物的方法。还描述了式I化合物的药用可接受的酸盐。式I的噻吩吡啶酮是降压剂,也适用于治疗心力衰竭和缺血性心脏病。